Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis - Wikidata - awgldk - TriplyDB

Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis

Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis

http://www.wikidata.org/entity/Q26823221

about

Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease Review article: the practical management of acute severe ulcerative colitis.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.Acute severe ulcerative colitis: from pathophysiology to clinical management.Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease.Acute severe ulcerative colitis: latest evidence and therapeutic implications.Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.

P2860

Q26745721-763AC628-0724-491B-B192-625480B3EF7C Q35883580-BEB62659-5134-4D93-B3D0-02DBAC2E0D1E Q38822920-E8F69889-8EF4-4CCC-865B-A68707F4F2CF Q38850063-7590EC2B-A91E-4043-91FA-20F2F15DF0FB Q38942561-009BF762-314F-48FF-A3D6-0B0BBF31DC7E Q39453169-FF38D76B-C307-4DB5-B642-DBF88282207D Q49232336-032F4318-BBC8-4C8E-8E37-791CFE072F51 Q51647910-AF519E23-F9BB-412B-95D7-B94886A2654C Q53815697-B6D0D532-FB10-4F91-A0B7-D84D2DD79534

P2860

Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis

http://www.wikidata.org/entity/Q26823221

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Review article: applying pharm ...... cute severe ulcerative colitis

@ast

Review article: applying pharm ...... cute severe ulcerative colitis

@en

Review article: applying pharm ...... cute severe ulcerative colitis

@nl

type

label

Review article: applying pharm ...... cute severe ulcerative colitis

@ast

Review article: applying pharm ...... cute severe ulcerative colitis

@en

Review article: applying pharm ...... cute severe ulcerative colitis

@nl

prefLabel

Review article: applying pharm ...... cute severe ulcerative colitis

@ast

Review article: applying pharm ...... cute severe ulcerative colitis

@en

Review article: applying pharm ...... cute severe ulcerative colitis

@nl

P1433

Q26823221-56CB69C4-00CA-4CC4-8B86-15B1F6FA5F18

P1476

Q26823221-9230A60F-5DE2-4B08-BE54-670EF6A87438

P2093

Q26823221-6552DBB3-1201-4A42-841C-B90CB7482437

Q26823221-85148EAD-B299-4F8E-8C96-CE299459717C

P2860

Q26823221-022E72E8-0327-42E5-8D69-9291CAC65974

Q26823221-104FA5DF-1ADE-420F-A70D-A29495722552

Q26823221-11072684-CDF9-401B-A46F-41569E584063

Q26823221-19A7C252-8D1A-41C2-953D-83DB4CF4252D

Q26823221-20FA1FBB-B944-47A2-8FA7-2C4C819D82A9

Q26823221-22C5506A-A57F-44F8-BBF8-F5DA3B90F9B7

Q26823221-2A97BC3E-2D71-4925-A28C-F8071650D1D8

Q26823221-2F42BBF4-80F6-4245-B4FF-E98186C1920A

Q26823221-321A3A4C-136E-40AE-A2DA-C7F1ECB9296C

Q26823221-34BDB961-24FE-46B3-8D60-D0FEA6BA8CD0

P304

Q26823221-E0F1FEA5-CDEC-47D0-8189-FBDA55323293

P31

Q26823221-2323B282-3F85-4706-82F1-FF55A8DD9B50

P356

Q26823221-A5E1C50F-2474-4848-ABB0-9310B0C6C9D0

P407

Q26823221-9BB0D104-3C1A-48B6-9CE3-2043A288B35B

P433

Q26823221-1FC5F9D0-0817-4FB4-9166-4005DC8023A1

P478

Q26823221-9067AF6A-C082-4851-A403-16435B8A9706

P50

Q26823221-6DF76AAA-C733-4410-9FB6-1F72623999A4

P577

Q26823221-967B588A-066C-4BAB-B4BF-E6718B7F1C08

P5875

Q26823221-3645D444-50F3-4E15-8471-DC04526D6A54

P698

Q26823221-D2610ED4-6AFF-4DA4-B05E-2891071C5E97

P921

Q26823221-69FE7C8A-DB0C-41DD-9E1D-7B2AF579C24E

Q26823221-8029F121-39A3-4F0A-8227-F676995E7C83

Q26823221-E4308E78-7358-43AA-B13B-5041A442DF3A

P932

Q26823221-BFAC928D-9ECE-45B3-980A-CBCFAFA60707

P356

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: applying pharm ...... cute severe ulcerative colitis

@en

P2093

M J Rosen

http://www.w3.org/2001/XMLSchema#string

P Minar

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Infliximab for induction and maintenance therapy for ulcerative colitis

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.

Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.

Significance of systemic endotoxaemia in inflammatory bowel disease.

Review article: medical treatment of severe ulcerative colitis.

Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.

Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression.

P304

1094-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.13175

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274092495

http://www.w3.org/2001/XMLSchema#string

P698

25809869

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics

P932

4498660

http://www.w3.org/2001/XMLSchema#string